A phase I study of vemurafenib and decitabine in metastatic melanoma

Abstract

Peer reviewed

Sneha Deepak Phadke, Eric Steven Engelman, Roberto Antonio Leon-Ferre, Laith I. Abushahin, Sarah C Mott, Yousef Zakharia and Mohammed M. Milhem

Journal of clinical oncology, Vol.33(15_suppl), pp.9056-9056

05/20/2015

DOI: 10.1200/jco.2015.33.15_suppl.9056

View Online

Title: Subtitle: A phase I study of vemurafenib and decitabine in metastatic melanoma
Creators: Sneha Deepak Phadke - University of Iowa
Eric Steven Engelman - Medcl Assoc Clinic, Dubuque, IA
Roberto Antonio Leon-Ferre - Mayo Clinic
Laith I. Abushahin - University of Iowa
Sarah C Mott - Holden Comprehensive Cancer Center, Iowa City, IA
Yousef Zakharia - University of Iowa
Mohammed M. Milhem - University of Iowa
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.33(15_suppl), pp.9056-9056
DOI: 10.1200/jco.2015.33.15_suppl.9056
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2015
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984363183402771

8 Record Views